G. Juillard et al., RESISTANCE TO COMMON VIRUSES DURING INTRALYMPHATIC INJECTIONS OF TUMOR-CELL VACCINES - CORRELATION WITH CIRCULATING CYTOKINES, American journal of clinical oncology, 18(3), 1995, pp. 226-230
Patients with advanced malignancies who received intralymphatic inject
ions of irradiated tumor cell suspensions (''vaccines'') were unexpect
edly found to be resistant to common viral diseases; 17 patients with
a documented past history of viral infections who have been observed f
or 48 to 148 months (median 108 months), were analyzed. The resistance
to viruses was found to correlate closely with the presence, in the s
erum, of certain cytokines. Specifically, the interleukins, -2, -6, -8
and interferon-gamma, at low but sustained levels appeared to be poss
ibly responsible for the nonspecific protection against viral infectio
ns obtained by intralymphatic injections of cellular material. These f
indings suggest that viral infections in normal or immunosuppressed in
dividuals at particular risk might be prevented by treatments aimed at
attaining very modest levels of certain cytokines.